Template:Non pregnant vaginal bleeding treatment
Revision as of 22:29, 26 February 2025 by Rossdonaldson1 (talk | contribs)
If you are concerned for malignancy, hormonal therapy should be avoided until patient can be evaluated by OBGYN for possible biopsy, since these medications may interfere with those results.
Mild Bleeding
- Iron supplementation
- 324mg ferrous sulfate tablet PO TID (each tab contains 65mg of elemental iron)
- NSAIDs
Moderate continued bleeding
Patients may benefit from initiation of short or long-term birth control for acute cessation.
Combined OCPs
- Any combined OCP that contains 35 ug of ethinyl estradiol TID for 7 days. (e.g., Ortho-Novum 1/35®)[1]
- 88% success, median time 3 days [2]
- Contraindications
- Cigarette smoking if older than 34 years
- Hypertension
- History of VTE
- Cerebrovascular disease
- CAD or valvular disease
- History of breast cancer
- Diabetes with vascular involvement
- Surgery with immobilization
- Liver cirrhosis
- Other pro-coagulative conditions (e.g. Lupus, Factor V Leiden)
- 20 mg PO TID for 7 days[1]
- 76% success, median time 3 days
- Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days
- In a trial of 48 patients all had cessation in 5 days.[3]
- Contraindications
- History of VTE
- History of arterial thromboembolic events
- History of breast cancer
- Liver disease
Life Threatening
- Establish large bore IV access
- Prepare for emergent blood transfusion uncrossmatched O-negative blood if typed blood is not available.
- It is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin
- If bleeding is due to a traumatic cause emergent surgical repair is necessary
- Tranexamic acid [4]
- Coordinate with OBGYN prior to administration due to the increased thrombotic risk
- Acutely 1.0-1.3 grams IV
- Then 1-1.3 g TID PO for 5 days
Pharmacologic Treatment Regimens For Acute Abnormal Uterine Bleeding[5][6]
| Drug | Suggested Dose | Contraindications |
| Conjugated equine estrogen | 25 mg IV every 4-6 h until bleeding stops, up to 24 h | Active or past thromboembolic disease, breast cancer, or liver disease |
| Combination oral contraceptive pills | 1 pill TID PO for 7 days or 1 pill bid PO for 5 days, then 1 pill daily until pack is finished | > 35 y who smoke, history of DVT or PE, breast cancer, liver disease, known thromboembolic disorders, pregnancy, ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension |
| Progestin-only oral contraceptive pills (medroxyprogesterone acetate) | 20 mg TID PO for 7 days or 10 mg daily PO for 10 days | Active or past DVT or PE, liver disease, or breast cancer |
| NSAIDs: Ibuprofen | 200-400 mg 3-4 times/day PO for 5 days | Advanced renal disease |
| Antifibrinolytic agents (tranexamic acid) | 1.3 g TID PO for up to 5 days | Active intravascular clotting or subarachnoid hemorrhage |
- ↑ 1.0 1.1 Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 121:891–6. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2013/04/management-of-acute-abnormal-uterine-bleeding-in-nonpregnant-reproductive-aged-women
- ↑ Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2006 Oct;108(4):924-9. doi: 10.1097/01.AOG.0000238343.62063.22. PMID: 17012455.
- ↑ Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.
- ↑ Leminen and Hurskainen. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012; 4: 413–421.
- ↑ American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 557: management of acute abnormal uterine bleeding in nonpregnant reproductiveaged women. Obstet Gynecol. 2013;121(4):891-896
- ↑ Tibbles CD. Selected gynecologic disorders: abnormal uterine bleeding in the nonpregnant patient. In: Marx JA, Hockberger RS, Walls RM, eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. Philadelphia, PA: Mosby-Elsevier; 2010: 1325-1332.
